Yüklüyor......
A new class of bronchodilator improves lung function in COPD: a trial with GSK961081
GSK961081 is a bifunctional molecule demonstrating both muscarinic antagonist and β-agonist activities. This was a 4-week, multicentre, randomised, double-blind, double-dummy, placebo and salmeterol controlled parallel group study. Doses ranging across three twice-daily doses and three once-daily do...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
European Respiratory Society
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3787816/ https://ncbi.nlm.nih.gov/pubmed/23429913 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/09031936.00165712 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|